Chemical formula: C₂₅H₂₆F₆N₂O₂ Molecular mass: 500.485 g/mol PubChem compound: 10311306
Rolapitant is indicated for:
Population group: only adults (18 years old or older)
Prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults. Rolapitant is given as part of combination therapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Rolapitant is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
